Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Bitterer, Floriana; * | Hornung, Matthiasa | Platz Batista da Silva, Nataschab | Schlitt, Hans J.a | Stroszczynski, Christianb | Wege, Anja K.c | Jung, Ernst-Michaelb
Affiliations: [a] Department of Surgery, University Hospital Regensburg, Regensburg, Germany | [b] Department of Radiology, University Hospital Regensburg, Regensburg, Germany | [c] Department of Gynecology and Obstetrics, University Medical Center Regensburg, Regensburg, Germany
Correspondence: [*] Corresponding author: Dr. med. Florian Bitterer, Universitätsklinikum Regensburg, Klinik und Poliklinik für Chirurgie, Franz-Josef-Strauß-Allee 11, 93053 Regensburg, Germany. Tel.: +49 941 9440; E-mail: [email protected].
Abstract: OBJECTIVE:To investigate the diagnostic accuracy of high-resolution ultrasound (HRU) for the detection of hepatic metastases of breast cancer in a humanized tumour mouse (HTM) using clinical standard technology. In addition, the efficiency of standard contrast-enhanced ultrasound (CEUS) [microbubbles of sulphur hexafluoride] and CEUS using a novel VEGFR2-targeted contrast agent [BR55®] was examined. METHODS:A total of 14 HTM were sonographically examined twice. In addition to a human immune system, the animals developed hepatic tumour lesions after intrahepatic injection of BT-474 breast cancer cells. Digital cine loops from the arterial phase (15–35 sec), the portal venous phase (35–90 sec) and the late phase (3–15 min) of the entire liver were analysed. Data were correlated to histopathology. RESULTS:After 9 months, half of the mice (7/14) revealed the development of hepatic breast cancer metastases. The detection limit was 1 mm tumour diameter. In particular, the use of targeted contrast media reduced the needed tumour diameter and helped to precisely classify tumour tissue. In 93% (13/14), the findings of ultrasound could be approved by histological examination by the pathologist. CONCLUSIONS:This study in HTM demonstrated the high feasibility of tumour specific contrast media and standard HRU contrast agents to detect early liver metastases.
Keywords: Abdomen, contrast-enhanced ultrasound (CEUS), BR55® , SonoVue® , humanized tumour mice (HTM)
DOI: 10.3233/CH-200898
Journal: Clinical Hemorheology and Microcirculation, vol. 76, no. 4, pp. 559-572, 2020
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]